Monitoring GLP-1 use among women newly diagnosed with PMOS helps characterize a rapidly evolving treatment landscape and how these therapies may coincide with changes in downstream treatment patterns
If you have achieved your weight loss goal entirely, the conversation shifts from dose escalation to dose maintenance, which is a different discussion that involves your provider and depends on individual factors like metabolic rate, dietary habits, and whether the weight remains stable at a reduced dose
More research needs to be done on feasibility, as some people may not tolerate more frequent or intense side effects with the higher GLP-1 dose
But before assuming that a GLP-1 medication has stopped working, clinicians will typically consider how the patient is using the drug, such as whether its being taken properly, with little to no missed doses, and whether it is being stored properly
They feel like the medication isnt working because the scale hasnt moved much